Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It

Gilead Sciences (GILD) Dips More Than Broader Market: What You Should Know

Gilead Sciences (GILD) Dips More Than Broader Market: What You Should Know

FDA Expands Indication for Gilead's Vemlidy (Tenofovir Alafenamide) to Treat Chronic HBV Infection in Pediatric Patients as Young as Six

Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program

7 Value Stocks to Buy at a 52-Week Low in March

Gilead bets on Xilio cancer drug as biotech restructures

Winn Awards Help Physicians Solve Healthcare Disparities

20 Biggest Health Care Companies in Australia, 2024

Gilead Sciences (GILD) Stock Moves -0.04%: What You Should Know

Gilead Sciences (GILD) Stock Moves -0.04%: What You Should Know

Gilead Sciences Announces Completion of Acquisition of CymaBay

Why Is Axsome (AXSM) Down 4% Since Last Earnings Report?

Why Is Axsome (AXSM) Down 4% Since Last Earnings Report?

Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know

Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know

Gilead Sciences (GILD) Rises But Trails Market: What Investors Should Know

Gilead Sciences (GILD) Rises But Trails Market: What Investors Should Know

Gilead Helps Launch Türkiye’s First HIV Testing Week

Center for Disease Analysis Foundation Announces First Round of Grantees for the CDAF-Relink Grant